Epidemiology of Venezuelan haemorrhagic fever in Barinas state, Venezuela

This study characterizes the epidemiology of Venezuelan haemorrhagic fever in western Venezuela, revealing that Guanarito virus causes a severe, seasonal disease with a high case fatality ratio (36.1%) predominantly affecting older men in agricultural occupations, distinguished by a unique clinical phenotype involving hemorrhage, sore throat, and gastrointestinal symptoms.

The Gist

Imagine Venezuela's western plains as a vast, quiet farm where a hidden, dangerous "ghost" has been living for decades. This ghost is a virus called Guanarito, which causes a scary illness known as Venezuelan Haemorrhagic Fever (VHF). While doctors have known about this ghost for years, they haven't really understood its habits or how it makes people feel until now.

A team of researchers decided to play detective. They looked at a giant stack of medical reports from 2017 to 2024, focusing on three specific states: Barinas, Apure, and Portuguesa. Think of these reports as clues left behind by people who felt sick.

Here is what their investigation revealed, broken down into simple stories:

1. The "Who" and "When"

Out of 480 people who were suspected of having this virus, only 72 (about 1 in 7) actually had it. But here is the scary part: the virus seems to have a favorite target. It mostly attacks older men (between 46 and 90 years old) who work outside, like farmers or people in service jobs.

It's also a seasonal ghost. The virus loves the "rainy season" of the year. Just like mosquitoes come out in the summer, this virus wakes up and becomes active between September and January. If you are an older man working in the fields during those months, you are in the danger zone.

2. The "What" (Symptoms)

When this virus strikes, it doesn't just give you a regular flu. The researchers compared it to other common tropical bugs like Dengue or Zika. They found that Guanarito is like a more aggressive bully.

While other viruses might give you a fever and a headache, Guanarito adds a special, terrifying mix of symptoms:

• Bleeding: This is the big red flag (haemorrhage).
• A very sore throat: Like swallowing glass.
• Stomach trouble: Diarrhea and belly pain.
• Severe body aches.

If you see a patient with a fever plus a sore throat plus bleeding, the researchers say, "Stop! This isn't just Dengue; this might be the Guanarito ghost."

3. The Danger Level

This is the most serious part of the story. The virus is incredibly deadly. Out of the people who were confirmed to have it, 36% died. That's more than 1 in 3.

The study showed that having this specific virus makes you nearly 4 times more likely to die compared to getting other common tropical fevers. It's not just a bad cold; it's a life-or-death situation.

The Bottom Line

The main takeaway is that this virus is still very much alive and kicking in western Venezuela. It hides in the rural areas, waiting for older men to work in the fields during the rainy season.

Because the symptoms look a bit like other common diseases, doctors in remote villages often miss the diagnosis. The researchers are saying, "Wake up, doctors! If you see an older farmer with a fever, a sore throat, and bleeding, treat it as a serious emergency immediately, even if you can't run a lab test right away."

In short: This paper is a warning label. It tells us exactly who the virus targets, when it strikes, and how to spot it before it's too late, so we can stop this deadly ghost from claiming more lives.

Technical Summary

Technical Summary: Epidemiology of Venezuelan Haemorrhagic Fever in Barinas State, Venezuela

1. Problem Statement

Venezuelan Haemorrhagic Fever (VHF), an emerging zoonotic disease caused by the Guanarito virus (GTOV), is endemic to the western plains of Venezuela. Despite being recognized for decades, critical gaps remain in understanding its epidemiology and clinical profile. Specifically, there is a lack of granular data regarding:

• The specific temporal and geographical transmission patterns within endemic regions.
• The distinct clinical phenotype of VHF compared to other prevalent arboviral infections (e.g., Dengue, Chikungunya, Zika).
• The severity and mortality risk associated with GTOV in the current epidemiological context.

2. Methodology

The study employed a retrospective analysis of individual-level surveillance data to characterize the disease burden and clinical presentation.

• Data Source: Standardized case report forms submitted to the Venezuelan National Epidemiological Surveillance System.
• Study Period: 2017 to 2024.
• Geographic Scope: Cases suspected of VHF in the states of Barinas, Apure, and Portuguesa.
• Variables Analyzed: Demographic data, clinical symptoms, and laboratory results.
• Comparative Approach: The study compared confirmed GTOV cases against cases of other endemic arboviral infections to delineate specific clinical markers.
• Statistical Analysis: Researchers calculated prevalence, seasonal patterns, and case fatality ratios (CFR). Multivariate analysis was used to determine the adjusted relative risk (aRR) of mortality associated with GTOV infection.

3. Key Results

• Case Confirmation: Out of 480 suspected cases, 72 (15.0%) were laboratory-confirmed as GTOV infections.
• Demographic Profile:
  • Gender/Occupation: Cases were predominantly male, specifically those engaged in agricultural or service-related occupations.
  • Age: The highest prevalence was observed in individuals aged 46 to 90 years.
• Seasonality: A distinct seasonal pattern was identified, with the majority of cases occurring between September and January.
• Clinical Phenotype:
  • Common Symptoms: Headache, hemorrhage, sore throat, and diarrhea were the most frequently reported.
  • Differentiation: GTOV infection was significantly more associated with headache, myalgia, sore throat, hemorrhage, and abdominal pain compared to infections caused by encephalitic alphaviruses, Chikungunya, Dengue, and Zika viruses. This establishes a unique clinical signature for VHF.
• Mortality and Severity:
  • The Case Fatality Ratio (CFR) among confirmed cases was 36.1% (95% CI: 25.1 to 48.3).
  • GTOV infection was an independent predictor of mortality, with an adjusted relative risk (aRR) of 3.66 (95% CI: 2.28 to 5.87; p < 0.001) compared to other arboviral infections.

4. Key Contributions

• Epidemiological Characterization: The study provides the first detailed, recent characterization of VHF transmission dynamics in western Venezuela over a seven-year period, identifying specific high-risk demographics (older agricultural males).
• Clinical Differentiation: It successfully defines a distinct clinical phenotype for GTOV, distinguishing it from other common arboviral diseases through specific symptom clusters (notably sore throat and hemorrhage).
• Quantification of Severity: The research quantifies the high mortality risk of VHF, confirming it as a significantly more lethal pathogen than other regional arboviruses.

5. Significance and Implications

• Clinical Awareness: The findings underscore the urgent need for clinicians in remote, endemic settings to maintain a high index of suspicion for VHF, particularly during the September–January season and in older male agricultural workers.
• Diagnostic Improvement: The distinct clinical profile suggests that differential diagnosis protocols should be updated to prioritize VHF testing when specific symptom combinations (hemorrhage + sore throat + GI symptoms) are present, even in the absence of immediate laboratory confirmation.
• Public Health Policy: The high CFR and specific risk factors highlight the necessity for improved surveillance systems and targeted public health interventions in the western plains of Venezuela to mitigate transmission and improve patient outcomes.